Jean J. Zhao
Broad Institute(US)Harvard University(US)Dana-Farber Cancer Institute(US)Dana-Farber/Harvard Cancer Center(US)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Cancer-related Molecular Pathways, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Targeting the phosphoinositide 3-kinase pathway in cancer(2009)2,742 cited
- → CDK4/6 inhibition triggers anti-tumour immunity(2017)1,483 cited
- → COT drives resistance to RAF inhibition through MAP kinase pathway reactivation(2010)1,444 cited
- → PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting(2014)1,325 cited
- → Essential roles of PI(3)K–p110β in cell growth, metabolism and tumorigenesis(2008)680 cited
- → Integrative Genomic Approaches Identify IKBKE as a Breast Cancer Oncogene(2007)626 cited
- → Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma